SEC Form 4 · accession 0001209191-17-037738
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S. Levine
Officer — SVP,General Counsel & Sec.
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2017 | M | 17,500 | $5.19 | A | 17,500 | D | |
| Common Stock | Jun 1, 2017 | S | 17,500 | $11.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $5.19 | Jun 1, 2017 | M | 17,500 | D | — | Apr 13, 2025 | Common Stock | 17,500 | 39,774 | D |
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
- F2This option vested as to 25% for the shares on April 14, 2016 and then in quarterly installments over 3 years thereafter.